Why AdaptImmune collected $27.5M from GSK
July 24, 2018 at 12:20 PM EDT
The two companies formed a partnership in 2014 to jointly develop T-cell therapies to treat cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.